Summary
We prospectively investigated the prognostic significance of free peritoneal tumour cells (FPTC) in a series of 118 patients with completely resected gastric carcinoma. Immunocytochemistry with the monoclonal antibody Ber-Ep4 was performed on cytospins from intraoperative peritoneal lavage specimens. Twenty-three patients (20%) had FPTC which was significantly correlated with pT and pN categories, stage, tumour size, lymphatic invasion, Laurèn and WHO classifications and perigastric adipose tissue metastases. The median survival time for all FPTC positive compared with negative patients was significantly shorter (11 compared with > 72 months), with estimated 5-year survival rates of 8% vs. 60%. None of the patients with FPTC had an early gastric cancer. In advanced tumour subgroups without and with serosal invasion (n = 59 and 35), there were 19% and 34% with FPTC. Multivariate survival analysis showed nodal status, FPTC, mesenteric lymphangiosis, and lymph node metastasis to the compartment III to be independent prognostic factors with relative risks of 6.6, 4.5, 2.9 and 2.2 respectively. Recurrent disease occurred in 91% of FPTC-positive and in 38% of FPTC-negative patients. FPTC had a positive predictive value of 91% and a specificity of 97% for tumour recurrence. FPTC is a strong negative, independent prognostic indicator for survival in gastric carcinoma.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abe, S., Yoshimura, H., Tabara, H., Tachibana, M., Monden, N., Nakamura, T. & Nagaoka, S. (1995). Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 59: 226–229.
Allum, W. H., Powell, D. J., McConkey, C. C. & Fielding, J. W. (1989). Gastric cancer: a 25-year review. Br J Surg 76: 535–540.
Asao, T., Fukuda, T., Yazawa, S. & Nagamachi, Y. (1989). CEA levels in peritoneal washings from gastric cancer patients as a prognostic guide. Cancer Lett 47: 79–81.
Boku, T., Nakane, Y., Minoura, T., Takada, H., Yamamura, M., Hioki, K. & Yamamoto, M. (1990). Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77: 436–439.
Bollschweiler, E., Boettcher, K., Hoelscher, A. H., Sasako, M., Kinoshita, T., Maruyama, K. & Siewert, J. R. (1993). Is the prognosis for Japanese and German patients with gastric cancer really different?. Cancer 71: 2918–2925.
Bonenkamp, J. J., van de Velde, C. J., Kampschoer, G. H., Hermans, J., Hermanek, P., Bemelmans, M., Gouma, D. J., Sasako, M. & Maruyama, K. (1993). Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J Surg 17: 410–414.
Bonenkamp, J. J., Songun, I., Hermans, J., Sasako, M., Welvaart, K., Plukker, J. T., van Elk, P., Obertop, H., Gouma, D. J. & Taat, C. W. (1995). Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345: 745–748.
Bonenkamp, J. J., Songun, I., Hermans, J. & van de Velde, C. J. (1996). Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83: 672–674.
Borrmann, R. (1926). Geschwulste des Magens und Duodenums. Handbuch der Speziellen Pathologischen Anatomie und Histologie, Henke F and Lubarsch O (eds.), pp. 865. Springer: Berlin
Broll, R., Lembcke, K., Stock, C., Zingler, M., Duchrow, M., Schimmelpenning, H., Strik, M., Muller, G., Kujath, P. & Bruch, H. P. (1996). Tumorzelldissemination in das knochenmark und in die peritonealhoehle. Eine immunzytochemische untersuchung an patienten mit einem magen; oder kolerektalen karzinom. Langenbecks Arch Chir 381: 51–58.
Chen, J. & Liu, Q. (1994). Identification and classification of serosal invasion, as it relates to cancer cell shedding and surgical treatment in gastric cancer. Semin Surg Oncol 10: 107–110.
Cox, D. (1972). Regression models and life-tables. J R Stat Soc 34: 187–220.
De Angelis, M., Buley, I. D., Heryet, A. & Gray, W. (1992). Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4. Cytopathology 3: 111–117.
Diaz-Arias, A. A., Loy, T. S., Bickel, J. T. & Chapman, R. K. (1993). Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases. Diagn Cytopathol 9: 516–521.
Hagiwara, A., Takahashi, T., Sawai, K., Taniguchi, H., Shimotsuma, M., Okano, S., Sakakura, C., Tsujimoto, H., Osaki, K. & Sasaki, S. (1993). Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 53: 687–692.
Hermanek, P. & Wittekind, C. (1995). News of TNM and its use for classification of gastric cancer. World J Surg 19: 491–495.
Iitsuka, Y., Shiota, S., Matsui, T., Murata, Y., Kimura, A. & Koga, S. (1990). Relationship between the cytologic characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol 34: 437–442.
Ikeguchi, M., Oka, A., Tsujitani, S., Maeta, M. & Kaibara, N. (1994). Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 14: 2131–2134.
Jaehne, J., Meyer, H. J., Soudah, B., Maschek, H. & Pichimayr, R. (1989). Peritoneal lavage in gastric carcinoma. Dig Surg 6: 26–28.
Japanese Research Society for Gastric Cancer (1981). The general rules for the gastric cancer study in surgery and pathology. II. Histological classification of gastric cancer. Jpn J Surg 11: 140–145.
Jauch, K. W., Heiss, M. M., Gruetzner, U., Funke, I., Pantel, K., Babic, R., Eissner, H. J., Riethmueller, G. & Schildberg, F. W. (1996). Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 14: 1810–1817.
Johnston, W. W., Szpak, C. A., Thor, A., Simpson, J. F. & Schlom, J. (1987). Applications of immunocytochemistry to clinical cytology. Cancer Invest 5: 593–611.
Juhl, H., Stritzel, M., Wroblewski, A., Henne-Bruns, D., Kremer, B., Schmiegel, W., Neumaier, M., Wagener, C., Schreiber, H. W. & Kalthoff, H. (1994). Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57: 330–335.
Kaibara, N., Iitsuka, Y., Kimura, A., Kobayashi, Y., Hirooka, Y., Nishidoi, H. & Koga, S. (1987). Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer 60: 136–139.
Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
Kiyasu, Y., Kaneshima, S. & Koga, S. (1981). Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 41: 1236–1239.
Koga, S., Kaibara, N., Iitsuka, Y., Kudo, H., Kimura, A. & Hiraoka, H. (1984). Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 108: 236–238.
Latza, U., Niedobitek, G., Schwarting, R., Nekarda, H. & Stein, H. (1990). Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43: 213–219.
Lauren, P. (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64: 31–49.
Lidang Jensen, M. & Johansen, P. (1994). Immunocytochemical staining of serous effusions: an additional method in the routine cytology practice?. Cytopathology 5: 93–103.
Nakajima, T., Harashima, S., Hirata, M. & Kajitani, T. (1978). Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 22: 225–229.
Nakamura, K., Ueyama, T., Yao, T., Xuan, Z. X., Ambe, K., Adachi, Y., Yakeishi, Y., Matsukuma, A. & Enjoji, M. (1992). Pathology and prognosis of gastric carcinoma. Findings in 10 000 patients who underwent primary gastrectomy. Cancer 70: 1030–1037.
Nakamura, T., Nekarda, H., Hoelscher, A. H., Bollschweiler, E., Harbeck, N., Becker, K., Siewert, J. R. & Harbec, N. H. (1994). Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett’s esophagus. Cancer 73: 1785–1794.
Nishiyama, M., Takashima, I., Tanaka, T., Yoshida, K., Toge, T., Nagata, N., Iwamori, S. & Tamura, Y. (1995). Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg 19: 133–137.
Noguchi, Y., Imada, T., Matsumoto, A., Coit, D. G. & Brennan, M. F. (1989). Radical surgery for gastric cancer. A review of the Japanese experience. Cancer 64: 2053–2062.
Parsons, S. L., Watson, S. A. & Steele, R. J. (1996). Malignant ascites. Br J Surg 83: 6–14.
Robinson, R. J. & Royston, D. (1993). Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells. Cytopathology 4: 267–271.
Roder, J. D., Bottcher, K., Siewert, J. R., Busch, R., Hermanek, P. & Meyer, H. J. (1993). Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 72: 2089–2097.
Roder, J. D., Bonenkamp, J. J., Craven, J., van de Velde, C. J., Sasako, M., Bottcher, K. & Stein, H. J. (1995). Lymphadenectomy for gastric cancer in clinical trials: update. World J Surg 19: 546–553.
Siewert, J. R., Bottcher, K., Roder, J. D., Busch, R., Hermanek, P. & Meyer, H. J. (1993). Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80: 1015–1018.
Siewert, J. R., Kestlmeier, R., Busch, R., Bottcher, K., Roder, J. D., Muller, J., Fellbaum, C. & Hofler, H. (1996). Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83: 1144–1147.
Simon, B., Podolsky, D. K., Moldenhauer, G., Isselbacher, K. J., Gattoni-Celli, S. & Brand, S. J. (1990). Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci USA 87: 2755–2759.
Spratt, J. S. (1986). Peritoneal carcinomatosis: anatomy, physiology, diagnosis, management. Curr Probl Cancer 10: 558–584.
Stoop, J. A., Hendriks, J. G. & Berends, D. (1992). Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA. Cytopathology 3: 297–302.
Thompson, G. B., van Heerden, J. A. & Sarr, M. G. (1993). Adenocarcinoma of the stomach: are we making progress?. Lancet 342: 713–718.
UICC (1993). TNM Atlas: an Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors, pp. 359. Springer-Verlag: Berlin
Watananbe, H., Jass, J. R. & Sobin, L. H. (1990). WHO Histological Typing of Oesophageal and Gastric Tumors, Springer: Berlin
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Nekarda, H., Geß, C., Stark, M. et al. Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma. Br J Cancer 79, 611–619 (1999). https://doi.org/10.1038/sj.bjc.6690096
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690096
Keywords
This article is cited by
-
New diagnostic strategy using narrow-band imaging (NBI) during laparoscopic surgery for patients with colorectal cancer
Surgical Endoscopy (2022)
-
The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma
Surgical Endoscopy (2013)
-
A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer
Gastric Cancer (2012)
-
R1-Resektion in der Chirurgie des oberen Gastrointestinaltrakts
Der Chirurg (2007)
-
Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives
Gastric Cancer (2007)